Skip to Main Content

Paper Details

Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review.
Res Pract Thromb Haemost
35
2020
Author NameAffiliation
Daniel TalmorCritical Care and Pain Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA.
  • 1 - 1

Datasets

Release 1.2